This insider cluster is too small in dollar terms to warrant a trading signal. Monitor for any material insider buying (C-suite open-market purchases) or a significant increase in selling volume (>0.5% of market cap) before adjusting positioning. The stock's 81% analyst bullish consensus and strong institutional ownership suggest no near-term catalyst from insider activity.
PTCT drugs
PTCT drug pipeline →How the stock moved after the report
NEUTRAL VIEWSTOCK BELOW ENTRY AT T+20- T+0 · Aug 24 $71.06entry
- T+1 · 3mo ago +3.39%α +3.07% · $73.47
- T+5 · 3mo ago −2.14%α −2.61% · $69.54
- T+20 · 8w ago −7.18%α −8.48% · $65.96
- T+59 · todayOpen
- T+60 · in 4h Pending
Price Chart
REPLAYWatch the reaction play outHow similar events traded
Executive Summary
Two insiders at PTC Therapeutics sold a total of $459K in open-market sales over a 7-day window. Director Michael Schmertzler sold $389K and EVP/CLO Mark Boulding sold $71K, with Boulding also exercising options. The total value is only ~0.008% of PTCT's $5.9B market cap, making this a trivial cluster by proportionality standards. The sales are routine and non-informative, no bearish signal from this activity.
Key Financial Metrics
Key Facts
- Two insiders sold a combined $459K in open-market sales over 7 days
- Director Michael Schmertzler sold $389K across multiple trades at ~$72
- EVP/CLO Mark Boulding sold $71K after exercising options at $25.69
- Total sales represent ~0.008% of PTCT's $5.9B market cap, trivial
- No C-suite cluster buys or material insider conviction signal present
Financial Impact
Total insider sales of $459K, or ~0.008% of market cap, immaterial
Risk Factors
- Insider selling could accelerate if management becomes less confident ahead of upcoming events
- The cluster is too small to be predictive, false signal risk if extrapolated
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 1 SEC document filed with EDGAR.
| Document | Accession Number |
|---|---|
| CLUSTER Data (Synthetic) | cluster-PTCT-1787378564222 |
Track record
29 reports on PTCT
4 of 6 bullish or bearish reports moved the stock their way by T+1. Best: +19.01% at T+60 after the Apr 28, 2026 report. 5 of 6 went positive at some point.
Filters
- Nov 16, 2026today SC 13G Neutral 3/10 Entry $62.09 Now $60.97 −1.80% settles Nov 17
- Nov 16, 2026today 144 Neutral 2/10 Entry $62.10 Now $60.97 −1.82% settles Nov 17
- Nov 16, 2026today SC 13G/A Neutral 3/10 Entry $63.45 Now $60.97 −3.91% settles Nov 17
- Nov 10, 20266d ago SC 13G Neutral 3/10 Entry $64.14 to $64.91 Now $60.97 −4.94% ▲ +1.20% −0.12% vs SPY
- Nov 3, 202613d ago 8-K Neutral 3/10 Entry $68.12 to $68.97 Now $60.97 −10.50% ▲ +1.25% −0.40% vs SPY
- Nov 3, 202613d ago Press Release Neutral 3/10 Entry $68.12 to $68.97 Now $60.97 −10.50% ▲ +1.25% −0.40% vs SPY
- Nov 2, 202614d ago Institutional Cluster Bearish 4/10 Entry $68.12 to $68.97 Now $60.97 +10.50% ▼ −1.25% +0.40% vs SPY
- Oct 29, 202618d ago 8-K Bullish 6/10 Entry $59.97 to $60.88 Now $60.97 +1.67% ▲ +1.52% +2.00% vs SPY
- Oct 27, 202620d ago Institutional Cluster Mixed 3/10 Entry $63.02 to $64.46 Now $60.97 −3.25% ▲ +2.29% +2.67% vs SPY
- Oct 16, 20264w ago Insider Cluster Neutral 3/10 Entry $61.53 to $62.92 Now $60.97 −0.91% ▲ +2.26% +1.92% vs SPY
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers